Chongqing Pharscin Pharmaceutical (002907.SZ) has completed the domestic production drug registration for three products.
Huarson Pharmaceuticals (002907.SZ) announcement, the company recently obtained information from the website of the China Food and Drug Administration that the company's...
Chongqing Pharscin Pharmaceutical (002907.SZ) announced that the company recently obtained information from the website of the National Medical Products Administration that three of the company's products have completed the domestic production drug filing (application for drug instructions suitability for the elderly) and the filing information has been publicly posted on the website of the National Medical Products Administration. The related products are: Ba Wei Qi Long Granules, Teng Xie Ning Granules, and Gan Ju Bing Mei Pian.
Related Articles
HSSP INTL (03626) stated that the company's public shareholding is not less than 25%, complying with the minimum public shareholding requirement.
Selected Announcement of A-shares | Nanjing Business & Tourism Corp.,Ltd.(600250.SH) Controlling Shareholder Nanjing Tourism Group Plans to Carry out Reform and Restructuring.
CICC: Active foreign capital continues to flow out, while passive foreign capital turns into inflow.
HSSP INTL (03626) stated that the company's public shareholding is not less than 25%, complying with the minimum public shareholding requirement.
Selected Announcement of A-shares | Nanjing Business & Tourism Corp.,Ltd.(600250.SH) Controlling Shareholder Nanjing Tourism Group Plans to Carry out Reform and Restructuring.
CICC: Active foreign capital continues to flow out, while passive foreign capital turns into inflow.
RECOMMEND
Anti-Overcompetition Drive Takes Hold Across Multiple Chinese Industries
04/07/2025
Bank of England Governor: Rise of Stablecoins May Undermine Confidence in National Currencies
04/07/2025
What the Passage of the “Big and Beautiful Act” Means for Americans: Gains and Losses Across Demographics
04/07/2025
